Influence of Immunosuppression on Patient Outcome After Liver Transplantation

By Mueller A.R.   Platz K.-P.   Willimski C.   Berg T.   Neuhaus R.   Lobeck H.   Neuhaus P.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1495-1496

Elsevier

Access to resources Recommend Favorite

-herpesvirus activation after kidney transplantation with mycophenolate mofetil-based maintenance immunosuppression

By Folkmane I.   Chapenko S.   Amerika D.   Bicans J.   Murovska M.   Rosentals R.  

Transplantation Proceedings, Vol. 33, Iss. 3, 2001-05 ,pp. : 2384-2385

Elsevier

Access to resources Recommend Favorite

Malignancies in Patients Under Long-Term Immunosuppression After Kidney Transplantation

By Behrend M.   Kolditz M.   Kliem V.   Oldhafer K.J.   Brunkhorst R.   Frei U.   Pichlmayr R.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 834-835

Elsevier

Access to resources Recommend Favorite

Immunosuppression and bone loss after transplantation

By Torregrosa J.V.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3665-3667

Elsevier

Access to resources Recommend Favorite

Successful results after 3 years' tacrolimus immunosuppression in abo-incompatible kidney transplantation recipients in japan

By Takahashi K.   Takahara S.   Uchida K.   Oshima S.   Toma H.   Sonoda T.   Japanese Tacrolimus Study Group  

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1604-1605

Elsevier

Access to resources Recommend Favorite